Determination of hexanal and Heptanal (cas 111-71-7) in human urine using magnetic solid phase extraction coupled with in-situ derivatization by high performance liquid chromatography

Add time:08/22/2019    Source:sciencedirect.com

In this study, magnetic solid phase extraction coupled with in-situ derivatization (MSPE-ISD) was established for the determination of hexanal and Heptanal (cas 111-71-7) in human urine. 2,4-Dinitrophenylhydrazine (DNPH) was used as the derivatization reagent that was adsorbed onto the surface of magnetite/silica/poly(methacrylic acid-co-ethylene glycol dimethacrylate) (Fe3O4/SiO2/P(MAA-co-EGDMA)). And then simultaneous extraction and derivatization of the aldehydes were performed on the DNPH-adsorbed Fe3O4/SiO2/P(MAA-co-EGDMA). The simple, rapid and sensitive determination of hexanal and heptanal can be accomplished within 9 min. Under optimized conditions, the limits of detection (LODs) were 1.7 and 2.5 nmol/L for hexanal and heptanal, respectively. The relative recoveries ranged from 72.8% to 91.4% with the intra- and inter-day relative standard deviations (RSDs) being less than 9.6%. Furthermore, the proposed method was successfully applied to determine endogenous hexanal and heptanal in human urine from healthy persons and lung cancer patients. The results showed the higher concentrations of hexanal and heptanal were observed in lung cancer patients compared to healthy controls. Thus, the developed MSPE-ISD method is suitable for the determination of aldehydes in urines.

We also recommend Trading Suppliers and Manufacturers of Heptanal (cas 111-71-7). Pls Click Website Link as below: cas 111-71-7 suppliers

Prev:Upgrading castor oil: From Heptanal (cas 111-71-7) to non-isocyanate poly(amide-hydroxyurethane)s
Next:A new configuration for bar adsorptive microextraction (BAμE) for the quantification of biomarkers (hexanal and Heptanal (cas 111-71-7)) in human urine by HPLC providing an alternative for early lung cancer diagnosis)